Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma

Table 1 Demographics of 12 patients with pancreatic adenosquamous carcinoma.

Case	Age/sex	Symptoms	Comorbidity	Laboratory data			Tumor markers
				Hb (g/dL)	Bil (T) (mg/dL)	Alk-P (U/L)	CEA (ng/mL)	CA 19-9 (U/mL)
1	73/F	Abd pain, BWL, jaundice	HTN	10.4	15.7	258	262	240
2	66/M	BWL, jaundice, anorexia	DM	10.2	14.8	438	13.1	>240
3	65/F	Abd pain, BWL, diarrhea	HTN, heart disease	13.4	0.4	89	25.2	15.7
4	63/M	Abd pain, BWL	Peptic ulcer	13.2	0.5	92	10.2	135
5	78/M	Abd pain, anorexia	Nil	10.6	0.7	78	12.4	142.4
6	79/M	Abd pain, BWL, anorexia, abd mass	Nil	12.6	0.5	95	17.6	8.5
7	38/F	Abd pain, BWL, jaundice	DM	10.7	23.2	192	14.5	138
8	79/F	Abd pain, dizziness, malaise	HTN, DM, Peptic ulcer	7.0	0.8	59	2300	>240
9	76/F	Abd pain, BWL	HTN	11.3	0.5	93	5.34	129
10	32/M	Abd pain, BWL	Peptic ulcer	15.2	0.5	84	1.79	84
11	69/F	Abd pain, BWL, anorexia	DM	9.4	0.5	66	83.74	>240
12	78/F	Abd pain, BWL, anorexia, malaise	HTN	10.6	0.3	68	0.57	160.9

Abd, abdominal; Alk-P, alkaline phosphatase; Bil (T): total bilirubin; BWL, body weight loss; CA19-9, carbohydrate antigen 19-9 (< 37 U/mL); CEA, carcinoembryonic antigen (< 5 ng/mL); DM, diabetes mellitus; Hb, hemoglobin; HTN, hypertension.

ISSN: 1477-7819